Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Chemotherapeutic drugs and human tumor cells cytokine network.

Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, Lokshin A, Gorelik E.

Int J Cancer. 2008 Nov 1;123(9):2031-40. doi: 10.1002/ijc.23732.

2.
3.

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.

Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE.

PLoS One. 2008 Aug 27;3(8):e3077. doi: 10.1371/journal.pone.0003077.

4.

CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.

Wang SW, Liu SC, Sun HL, Huang TY, Chan CH, Yang CY, Yeh HI, Huang YL, Chou WY, Lin YM, Tang CH.

Carcinogenesis. 2015 Jan;36(1):104-14. doi: 10.1093/carcin/bgu218. Epub 2014 Oct 20.

PMID:
25330803
5.

Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.

Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH.

Cancer Res. 2005 Aug 1;65(15):6934-42. Erratum in: Cancer Res. 2005 Dec 1;65(23):11228.

7.

Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.

Kaga T, Kawano H, Sakaguchi M, Nakazawa T, Taniyama Y, Morishita R.

Vascul Pharmacol. 2012 Aug 19;57(1):3-9. doi: 10.1016/j.vph.2012.02.002. Epub 2012 Feb 14.

PMID:
22361334
9.

A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin.

Merighi S, Simioni C, Gessi S, Varani K, Mirandola P, Tabrizi MA, Baraldi PG, Borea PA.

Neoplasia. 2009 Oct;11(10):1064-73.

10.

Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.

Am J Pathol. 1998 Jun;152(6):1433-43.

11.

Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.

Gong SJ, Jin CJ, Rha SY, Chung HC.

Cancer Lett. 2004 Oct 28;214(2):215-24.

PMID:
15363548
12.

Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines.

Grepin R, Guyot M, Jacquin M, Durivault J, Chamorey E, Sudaka A, Serdjebi C, Lacarelle B, Scoazec JY, Negrier S, Simonnet H, Pages G.

Oncogene. 2012 Mar 29;31(13):1683-94. doi: 10.1038/onc.2011.360. Epub 2011 Sep 12.

PMID:
21909141
14.

Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts.

Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY, Lee SY, Park MK, Min JK, Park SH, Lee SH, Kim HY.

Immunol Lett. 2007 Feb 15;108(2):121-8. Epub 2006 Dec 11.

PMID:
17182109
15.

IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.

Caiello I, Minnone G, Holzinger D, Vogl T, Prencipe G, Manzo A, De Benedetti F, Strippoli R.

PLoS One. 2014 Oct 1;9(10):e107886. doi: 10.1371/journal.pone.0107886. eCollection 2014.

16.

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.

Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, Yu H.

Oncogene. 2005 Aug 25;24(36):5552-60.

PMID:
16007214
17.

Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.

Takahashi H, Numasaki M, Lotze MT, Sasaki H.

Immunol Lett. 2005 May 15;98(2):189-93. Epub 2004 Dec 8.

PMID:
15860217
18.

Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.

Ngan BY, Forte V, Campisi P.

Arch Otolaryngol Head Neck Surg. 2008 Nov;134(11):1170-6. doi: 10.1001/archotol.134.11.1170.

PMID:
19015446
19.

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.

Kerbel RS, Viloria-Petit A, Klement G, Rak J.

Eur J Cancer. 2000 Jun;36(10):1248-57. Review.

PMID:
10882863
20.

Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.

Lee CC, Liu KJ, Wu YC, Lin SJ, Chang CC, Huang TS.

Inflammation. 2011 Jun;34(3):209-21. doi: 10.1007/s10753-010-9226-z.

PMID:
20617373

Supplemental Content

Support Center